Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03095976 · ClinicalTrials.gov registry record · NA
Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03095976: Completed NA study, sponsored by Indiana University.
NCT03095976 is a NA study that has completed, run by Indiana University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03095976, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this pilot project is to evaluate the efficacy of application of Amnion-Chorion allograft membrane on the root surface of periodontally diseased teeth in conjunction with bone substitute covered by Amnion-Chorion allograft in a combination Guided Tissue Regeneration (GTR) treatment of periodontal intrabony and furcation defects.
Primary Outcome
Probing depth was measured at intrabony defect following surgical procedure.
Interventions
- PROCEDURE Amnion-Chorion allograft membrane on the root surface of periodontally diseased site.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-06-14 |
| Est. Completion | 2019-09-10 |
| Phase | NA |
What the finished NCT03095976 record still lists
NCT03095976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Amnion-Chorion allograft membrane on the root surface of periodontally diseased site. is the first listed.
NCT03095976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03095976 about?
NCT03095976 is a clinical study titled "Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration". The purpose of this pilot project is to evaluate the efficacy of application of Amnion-Chorion allograft membrane on the root surface of periodontally diseased teeth in conjunction with bone substitute covered by Amnion-Chorion allograft in a combination Guided Tissue Regeneration (GTR) treatment of...
What is the current status of trial NCT03095976?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-06-14. Estimated completion is 2019-09-10.
What interventions are being tested in trial NCT03095976?
The interventions under investigation include: Amnion-Chorion allograft membrane on the root surface of periodontally diseased site. (PROCEDURE).
Who is sponsoring clinical trial NCT03095976?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03095976's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI